(Q50733796)

English

The insulin glargine dilemma: an opportunity for the diabetes community?

scientific article published on 14 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

The insulin glargine dilemma: an opportunity for the diabetes community? (English)

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

M Stumvoll

1

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

P P Nawroth

2

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

publication date

14 August 2009

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

52

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

10

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

1987-1989

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

https://scigraph.springernature.com/pub.10.1007/s00125-009-1490-9

0 references

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-009-1490-9

21 January 2018

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does diabetes therapy influence the risk of cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19680625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-009-1490-9

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

1 reference

Europe PubMed Central

18 March 2018

http://europepmc.org/abstract/MED/19680625

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50733796&oldid=1563398902"